News
ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer. Efficacy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback